Items per page
Sort by

Send to:

Choose Destination

Results: 17


Enhanced photochemistry of ethyl chloride on Ag nanoparticles.

Toker G, Bespaly A, Zilberberg L, Asscher M.

Nano Lett. 2015 Feb 11;15(2):936-42. doi: 10.1021/nl503700y. Epub 2015 Jan 7.


Function of latent TGFβ binding protein 4 and fibulin 5 in elastogenesis and lung development.

Dabovic B, Robertson IB, Zilberberg L, Vassallo M, Davis EC, Rifkin DB.

J Cell Physiol. 2015 Jan;230(1):226-36. doi: 10.1002/jcp.24704.


Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5.

Noda K, Dabovic B, Takagi K, Inoue T, Horiguchi M, Hirai M, Fujikawa Y, Akama TO, Kusumoto K, Zilberberg L, Sakai LY, Koli K, Naitoh M, von Melchner H, Suzuki S, Rifkin DB, Nakamura T.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2852-7. doi: 10.1073/pnas.1215779110. Epub 2013 Feb 4.


Reactive-layer-assisted deposition mechanism and characterization of titanium oxide films.

Zilberberg L, Asscher M.

Langmuir. 2012 Dec 11;28(49):17118-23. doi: 10.1021/la302957q. Epub 2012 Nov 28.


Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin.

Zilberberg L, Todorovic V, Dabovic B, Horiguchi M, Couroussé T, Sakai LY, Rifkin DB.

J Cell Physiol. 2012 Dec;227(12):3828-36. doi: 10.1002/jcp.24094.


Long form of latent TGF-β binding protein 1 (Ltbp1L) regulates cardiac valve development.

Todorovic V, Finnegan E, Freyer L, Zilberberg L, Ota M, Rifkin DB.

Dev Dyn. 2011 Jan;240(1):176-87. doi: 10.1002/dvdy.22521.


Control of lung development by latent TGF-β binding proteins.

Dabovic B, Chen Y, Choi J, Davis EC, Sakai LY, Todorovic V, Vassallo M, Zilberberg L, Singh A, Rifkin DB.

J Cell Physiol. 2011 Jun;226(6):1499-509. doi: 10.1002/jcp.22479.


Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development.

Urban Z, Hucthagowder V, Schürmann N, Todorovic V, Zilberberg L, Choi J, Sens C, Brown CW, Clark RD, Holland KE, Marble M, Sakai LY, Dabovic B, Rifkin DB, Davis EC.

Am J Hum Genet. 2009 Nov;85(5):593-605. doi: 10.1016/j.ajhg.2009.09.013. Epub 2009 Oct 15.


Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.

Ono RN, Sengle G, Charbonneau NL, Carlberg V, Bächinger HP, Sasaki T, Lee-Arteaga S, Zilberberg L, Rifkin DB, Ramirez F, Chu ML, Sakai LY.

J Biol Chem. 2009 Jun 19;284(25):16872-81. doi: 10.1074/jbc.M809348200. Epub 2009 Apr 6.


p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice.

Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB, Ramirez F.

J Biol Chem. 2009 Feb 27;284(9):5630-6. doi: 10.1074/jbc.M806962200. Epub 2008 Dec 24.


Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors.

Yoshinaga K, Obata H, Jurukovski V, Mazzieri R, Chen Y, Zilberberg L, Huso D, Melamed J, Prijatelj P, Todorovic V, Dabovic B, Rifkin DB.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18758-63. doi: 10.1073/pnas.0805411105. Epub 2008 Nov 20.


A rapid and sensitive bioassay to measure bone morphogenetic protein activity.

Zilberberg L, ten Dijke P, Sakai LY, Rifkin DB.

BMC Cell Biol. 2007 Sep 19;8:41.


Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A.

J Biol Chem. 2003 Sep 12;278(37):35564-73. Epub 2003 Jul 1.


Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.

Cancer Res. 2002 Dec 1;62(23):6884-90.


Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity.

Lozano RM, Redondo-Horcajo M, Jimenez MA, Zilberberg L, Cuevas P, Bikfalvi A, Rico M, Giménez-Gallego G.

J Biol Chem. 2001 Sep 21;276(38):35723-34. Epub 2001 Jun 21.


A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.

Hagedorn M, Zilberberg L, Lozano RM, Cuevas P, Canron X, Redondo-Horcajo M, Gimenez-Gallego G, Bikfalvi A.

FASEB J. 2001 Mar;15(3):550-2. Epub 2001 Jan 5.


Effect of distal hamstring release on cerebral palsy patients.

Atar D, Zilberberg L, Votemberg M, Norsy M, Galil A.

Bull Hosp Jt Dis. 1993 Spring;53(1):34-6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk